120 related articles for article (PubMed ID: 31665225)
1. Premenopausal Use of Progestogens and Cutaneous Melanoma Risk: A French Prospective Cohort Study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Boutron-Ruault MC; Fournier A; Kvaskoff M
Am J Epidemiol; 2020 Apr; 189(4):314-329. PubMed ID: 31665225
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous melanoma and endogenous hormonal factors: a large French prospective study.
Kvaskoff M; Bijon A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
Am J Epidemiol; 2011 May; 173(10):1192-202. PubMed ID: 21415032
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study.
Cervenka I; Mahamat-Saleh Y; Savoye I; Dartois L; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2018 Nov; 143(10):2390-2399. PubMed ID: 29978471
[TBL] [Abstract][Full Text] [Related]
5. Fertility drugs and cutaneous melanoma risk: a French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Boutron-Ruault MC; Fournier A; Kvaskoff M
Eur J Cancer Prev; 2020 Mar; 29(2):182-185. PubMed ID: 31764213
[TBL] [Abstract][Full Text] [Related]
6. Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008.
Fournier A; Dossus L; Mesrine S; Vilier A; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N
Am J Epidemiol; 2014 Sep; 180(5):508-17. PubMed ID: 25008104
[TBL] [Abstract][Full Text] [Related]
7. Statin Use and Skin Cancer Risk: A Prospective Cohort Study.
Al Rahmoun M; Ghiasvand R; Cairat M; Mahamat-Saleh Y; Cervenka I; Severi G; Boutron-Ruault MC; Robsahm TE; Kvaskoff M; Fournier A
J Invest Dermatol; 2022 May; 142(5):1318-1325.e5. PubMed ID: 34695411
[TBL] [Abstract][Full Text] [Related]
8. Mediterranean dietary pattern and skin cancer risk: A prospective cohort study in French women.
Mahamat-Saleh Y; Cervenka I; Al Rahmoun M; Savoye I; Mancini FR; Trichopoulou A; Boutron-Ruault MC; Kvaskoff M
Am J Clin Nutr; 2019 Oct; 110(4):993-1002. PubMed ID: 31380561
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort.
Madika AL; MacDonald CJ; Fournier A; Mounier-Vehier C; Béraud G; Boutron-Ruault MC
Menopause; 2021 Sep; 28(11):1204-1208. PubMed ID: 34581294
[TBL] [Abstract][Full Text] [Related]
10. Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women.
Kvaskoff M; Mesrine S; Fournier A; Boutron-Ruault MC; Clavel-Chapelon F
Arch Intern Med; 2007 Oct; 167(19):2061-5. PubMed ID: 17954799
[TBL] [Abstract][Full Text] [Related]
11. Female hormonal exposures and risk of rheumatoid arthritis in the French E3N-EPIC cohort study.
Salliot C; Nguyen Y; Gusto G; Gelot A; Gambaretti J; Mariette X; Boutron-Ruault MC; Seror R
Rheumatology (Oxford); 2021 Oct; 60(10):4790-4800. PubMed ID: 33547777
[TBL] [Abstract][Full Text] [Related]
12. E3N, a French cohort study on cancer risk factors. E3N Group. Etude Epidémiologique auprès de femmes de l'Education Nationale.
Clavel-Chapelon F; van Liere MJ; Giubout C; Niravong MY; Goulard H; Le Corre C; Hoang LA; Amoyel J; Auquier A; Duquesnel E
Eur J Cancer Prev; 1997 Oct; 6(5):473-8. PubMed ID: 9466118
[TBL] [Abstract][Full Text] [Related]
13. Micronutrient dietary patterns associated with type 2 diabetes mellitus among women of the E3N-EPIC (Etude Epidémiologique auprès de femmes de l'Education Nationale) cohort study.
Mancini FR; Dow C; Affret A; Rajaobelina K; Dartois L; Balkau B; Bonnet F; Boutron-Ruault MC; Fagherazzi G
J Diabetes; 2018 Aug; 10(8):665-674. PubMed ID: 29457678
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) cohort.
de Lauzon-Guillain B; Fournier A; Fabre A; Simon N; Mesrine S; Boutron-Ruault MC; Balkau B; Clavel-Chapelon F
Diabetologia; 2009 Oct; 52(10):2092-100. PubMed ID: 19629429
[TBL] [Abstract][Full Text] [Related]
15. Anthropometric features and cutaneous melanoma risk: a prospective cohort study in French women.
Kvaskoff M; Bijon A; Mesrine S; Vilier A; Clavel-Chapelon F; Boutron-Ruault MC
Cancer Epidemiol; 2014 Aug; 38(4):357-63. PubMed ID: 24986641
[TBL] [Abstract][Full Text] [Related]
16. Gonadal hormonal factors before menopause and incident type 2 diabetes in women: A 22-year follow-up of 83 799 women from the E3N cohort study.
Tatulashvili S; Gusto G; Cosson E; Balkau B; Gourdy P; Bonnet F; Bihan H; Fagherazzi G
J Diabetes; 2021 Apr; 13(4):330-338. PubMed ID: 33145935
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics and determinants of initiation of premenopausal use of oral progestagens in the French E3N cohort].
Fabre A; Fournier A; Mesrine S; Ringa V; Clavel-Chapelon F
J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):310-7. PubMed ID: 20452148
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Ultraviolet Radiation Exposure and Skin Cancer Risk: the E3N-SunExp Study.
Savoye I; Olsen CM; Whiteman DC; Bijon A; Wald L; Dartois L; Clavel-Chapelon F; Boutron-Ruault MC; Kvaskoff M
J Epidemiol; 2018 Jan; 28(1):27-33. PubMed ID: 29176271
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid consumption and incident type 2 diabetes: an 18-year follow-up in the female E3N (Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l'Education Nationale) prospective cohort study.
Dow C; Mangin M; Balkau B; Affret A; Boutron-Ruault MC; Clavel-Chapelon F; Bonnet F; Fagherazzi G
Br J Nutr; 2016 Nov; 116(10):1807-1815. PubMed ID: 27842617
[TBL] [Abstract][Full Text] [Related]
20. Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Fournier A; Boutron-Ruault MC; Severi G; Caini S; Palli D; Ghiasvand R; Veierod MB; Botteri E; Tjønneland A; Olsen A; Fortner RT; Kaaks R; Schulze MB; Panico S; Trichopoulou A; Dessinioti C; Niforou K; Sieri S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Sandanger TM; Colorado-Yohar S; Sánchez MJ; Gil Majuelo L; Lujan-Barroso L; Ardanaz E; Merino S; Isaksson K; Butt S; Ljuslinder I; Jansson M; Travis RC; Khaw KT; Weiderpass E; Dossus L; Rinaldi S; Kvaskoff M
Int J Cancer; 2020 Jun; 146(12):3267-3280. PubMed ID: 31506954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
